The Magazine for Sleep Professionals
Friday, September 25, 2026
ResMed and Verily, an Alphabet company, announced their agreement to form a new joint venture. Combining ResMed’s expertise in sleep apnea and Verily’s advanced health data analytics technologies, the U.S.-based joint venture will study the health and financial impacts of undiagnosed and untreated sleep apnea, and develop software solutions that […]
Ebb Therapeutics, a medtech start-up initially focused on the development of innovative medical devices that help the millions of U.S. insomnia sufferers to more quickly find deeper, more restorative sleep, announced today the appointment of Elise Wilfinger as its Chief Marketing Officer. Wilfinger will commute between headquarters in Pittsburgh and her home office in Ridgefield, […]
New Data Also Reveals Some Surprising Differences in How Americans Sleep Based on Gender and Geography New internal data from Sleep Cycle, the best-selling alarm clock application, reveals how seasons affect our shut-eye. It turns out that even though most Americans like a cold sleeping environment, they do their best sleeping […]
Foothill Regional Medical Center in Tustin houses one of only eight pediatric subacute programs in California and the only hospital-based program serving Orange County. Five-year-old Junior Reyes is one of the program’s patients. He was born with a rare neurological condition that affects all his muscles, including his breathing. His […]
Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in Pulmonary Therapy, indicates significant reductions in costs when using the AEROBIKA® oscillating positive expiratory pressure (OPEP) device in the postoperative care setting.1 The retrospective database analysis including 288 patients undergoing cardiac, thoracic […]
Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Efficacy […]
Administration of nitric oxide gas during and for 24 hours following heart surgery decreased the risk of patients developing acute and chronic kidney problems, a randomized, controlled trial conducted in China found. The study, “Nitric Oxide Decreases Acute Kidney Injury and Stage 3 Chronic Kidney Disease after Cardiac Surgery,” is […]
Melbourne, Australia based nasal respiratory company Rhinomed is pleased to advise investors that it has signed a non-binding term sheet with Columbia Care LLC (“Columbia Care”) to license Rhinomed’s nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogs and derivatives. The non-binding term sheet sets out proposed terms […]
Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on June 05, 2018, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest […]
Masimo and Thermomedics, a PositiveID company, announced today the debut and U.S. market release of TIR-1™, a non-contact Bluetooth®-enabled thermometer that integrates seamlessly with the Masimo Root® patient monitoring and connectivity platform. TIR-1 is an easy-to-use, clinical-grade infrared thermometer that provides forehead temperature measurements across all patient populations. As a non-contact device, the thermometer […]
